Founded

Address

Kolltan Pharmaceuticals Inc
300 George Street
Suite 530
New Haven, CT 06511
United States

Open map

Phone
KANDO id: 349622

Corporate information

Registration country

Official identities

US CIK 0001442835

Company type

Oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases.

Funding rounds

Series A


( )

Profile Country
HBM BioVentures AG

Profile Country
Hatteras Venture Partners II (HVP II)

Profile Country
Elm Street Ventures


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials